BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 27736763)

  • 1. Using MRSA Screening Tests To Predict Methicillin Resistance in Staphylococcus aureus Bacteremia.
    Butler-Laporte G; Cheng MP; Cheng AP; McDonald EG; Lee TC
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7444-7448. PubMed ID: 27736763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia.
    Roghmann MC
    Arch Intern Med; 2000 Apr; 160(7):1001-4. PubMed ID: 10761966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid detection of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) using the KeyPath MRSA/MSSA blood culture test and the BacT/ALERT system in a pediatric population.
    Sullivan KV; Turner NN; Roundtree SS; McGowan KL
    Arch Pathol Lab Med; 2013 Aug; 137(8):1103-5. PubMed ID: 23899068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.
    Arshad S; Huang V; Hartman P; Perri MB; Moreno D; Zervos MJ
    Int J Infect Dis; 2017 Apr; 57():27-31. PubMed ID: 28131729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to First Culture Positivity Among Critically Ill Adults With Methicillin-Resistant
    Melling PA; Noto MJ; Rice TW; Semler MW; Stollings JL
    Ann Pharmacother; 2020 Feb; 54(2):131-137. PubMed ID: 31544471
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.
    Canty E; Carnahan B; Curley T; Anususinha E; Hamdy RF; Ericson JE
    Pediatr Infect Dis J; 2021 May; 40(5):429-433. PubMed ID: 33196562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of methicillin-resistant Staphylococcus aureus bacteremia and comparison of prognosis according to vancomycin MIC values: experience of the last ten years].
    Kızılarslanoğlu MC; Sancak B; Yağcı S; Hasçelik G; Unal S
    Mikrobiyol Bul; 2013 Apr; 47(2):199-210. PubMed ID: 23621720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection.
    McNeil JC; Kaplan SL; Vallejo JG
    Pediatr Infect Dis J; 2017 Jun; 36(6):572-577. PubMed ID: 28027279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.
    McConeghy KW; Bleasdale SC; Rodvold KA
    Clin Infect Dis; 2013 Dec; 57(12):1760-5. PubMed ID: 23985343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
    Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin Improves Outcomes Regardless of Vancomycin MIC in a Propensity-Matched Analysis of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
    Claeys KC; Zasowski EJ; Casapao AM; Lagnf AM; Nagel JL; Nguyen CT; Hallesy JA; Compton MT; Kaye KS; Levine DP; Davis SL; Rybak MJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5841-8. PubMed ID: 27431221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-Susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable
    Jones D; Elshaboury RH; Munson E; Dilworth TJ
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038267
    [No Abstract]   [Full Text] [Related]  

  • 13. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
    Panesso D; Planet PJ; Diaz L; Hugonnet JE; Tran TT; Narechania A; Munita JM; Rincon S; Carvajal LP; Reyes J; Londoño A; Smith H; Sebra R; Deikus G; Weinstock GM; Murray BE; Rossi F; Arthur M; Arias CA
    Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.
    Song KH; Kim M; Kim CJ; Cho JE; Choi YJ; Park JS; Ahn S; Jang HC; Park KH; Jung SI; Yoon N; Kim DM; Hwang JH; Lee CS; Lee JH; Kwak YG; Kim ES; Park SY; Park Y; Lee KS; Lee YS; Kim HB
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized phase 2B trial of vancomycin versus daptomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteremia due to isolates with high vancomycin minimum inhibitory concentrations - results of a prematurely terminated study.
    Kalimuddin S; Chan YFZ; Phillips R; Ong SP; Archuleta S; Lye DC; Tan TT; Low JGH
    Trials; 2018 Jun; 19(1):305. PubMed ID: 29859132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteremia due to Methicillin-Resistant Staphylococcus aureus: An Update on New Therapeutic Approaches.
    Holubar M; Meng L; Alegria W; Deresinski S
    Infect Dis Clin North Am; 2020 Dec; 34(4):849-861. PubMed ID: 33011050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting high vancomycin minimum inhibitory concentration isolate infection among patients with community-onset methicillin-resistant Staphylococcus aureus bacteraemia.
    Chen SY; Hsueh PR; Chiang WC; Huang EP; Lin CF; Chang CH; Chen SC; Chen WJ; Chang SC; Lai MS; Chie WC
    J Infect; 2014 Sep; 69(3):259-65. PubMed ID: 24797078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.
    Ahmad NM; Rojtman AD
    Ann Pharmacother; 2010 May; 44(5):918-21. PubMed ID: 20354160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections.
    Kopp BJ; Nix DE; Armstrong EP
    Ann Pharmacother; 2004 Sep; 38(9):1377-82. PubMed ID: 15266044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an assay that enables rapid determination of Staphylococcus species and their drug susceptibility on the treatment of patients with positive blood culture results.
    Parta M; Goebel M; Thomas J; Matloobi M; Stager C; Musher DM
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1043-8. PubMed ID: 20731594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.